- Home
- ABSI
ABSI
Absci Corporation
as 01-22-2025 9:30am EST
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 318.2M | IPO Year: | 2021 |
| Target Price: | $8.50 | AVG Volume (30 days): | 5.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.45 - $6.72 | Next Earning Date: | 11-12-2024 |
| Revenue: | $4,207,000 | Revenue Growth: | -39.35% |
| Revenue Growth (this year): | 8.57% | Revenue Growth (next year): | 169.72% |
Latest Absci Corporation News
ABSI Breaking Stock News: Dive into ABSI Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
Absci Corporation (ABSI): AI in Biopharma Discovery
TipRanks
11 days ago
Absci, Owkin announce partnership to bring together AI platforms
Insider Monkey
12 days ago
Advanced Micro Devices (AMD) Invests in Absci for AI-Driven Drug Discovery with High-Performance Computing Solutions
MT Newswires
12 days ago
Absci Partners With Owkin to Develop Immuno-oncology Treatment Candidates
GlobeNewswire
12 days ago
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
GuruFocus.com
14 days ago
AMD Shares Slide as HSBC Downgrades Stock Over Nvidia Concerns; Absci Collaboration Announced
MT Newswires
14 days ago
Sector Update: Health Care Stocks Rise Premarket Wednesday
Benzinga
14 days ago
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
Compare ABSI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABSI Absci Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.